Your Messages Inbox
Your Article Summary
See Latest ArticlesTeva Announces Approval and Launch of Tri-Lo Sprintec Tablets
Teva Pharmaceutical Industries, 07/02/09
Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application to market a generic version of Ortho McNeil Janssen's oral contraceptive, Ortho Tri-Cyclen Lo. Shipment of this product, for which Teva's trade name is Tri-Lo Sprintec, has commenced.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
Genzyme, 11/19/09
Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Wearable Sensors to Detect Agents, Disease
HealthDataManagement, 11/23/09
Medtronic Chairman and CEO Bill Hawkins Comments on U.S. Senates Revised Medical Device Industry Fee Proposal
Medtronic, 11/20/09
Sanofi-aventis and Medicines for Malaria Venture to launch the largest ever study of an antimalarial drug
Sanofi-aventis, 11/20/09
Article Search
Sponsor